282 related articles for article (PubMed ID: 26898738)
1. Nanoparticulate Drug Delivery to Colorectal Cancer: Formulation Strategies and Surface Engineering.
Tran TT; Tran PH; Wang Y; Li P; Kong L
Curr Pharm Des; 2016; 22(19):2904-12. PubMed ID: 26898738
[TBL] [Abstract][Full Text] [Related]
2. Manufacturing Techniques and Surface Engineering of Polymer Based Nanoparticles for Targeted Drug Delivery to Cancer.
Wang Y; Li P; Truong-Dinh Tran T; Zhang J; Kong L
Nanomaterials (Basel); 2016 Feb; 6(2):. PubMed ID: 28344283
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable Particulate Carrier Formulation and Tuning for Targeted Drug Delivery.
Tammam SN; Azzazy HM; Lamprecht A
J Biomed Nanotechnol; 2015 Apr; 11(4):555-77. PubMed ID: 26310064
[TBL] [Abstract][Full Text] [Related]
4. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin immuno hybrid nanoparticles for active targeting: an approach for enhanced apoptotic activity and drug delivery to colorectal tumors.
Tummala S; Gowthamarajan K; Satish Kumar MN; Wadhwani A
Drug Deliv; 2016 Jun; 23(5):1773-87. PubMed ID: 26377238
[TBL] [Abstract][Full Text] [Related]
6. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
[TBL] [Abstract][Full Text] [Related]
7. Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery.
Elzoghby AO; Abd-Elwakil MM; Abd-Elsalam K; Elsayed MT; Hashem Y; Mohamed O
Curr Pharm Des; 2016; 22(22):3305-23. PubMed ID: 26845323
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable polymeric nanoparticles based drug delivery systems.
Kumari A; Yadav SK; Yadav SC
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):1-18. PubMed ID: 19782542
[TBL] [Abstract][Full Text] [Related]
9. Lipid-coated polymeric nanoparticles for cancer drug delivery.
Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM
Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931
[TBL] [Abstract][Full Text] [Related]
10. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
Bhunchu S; Rojsitthisak P
Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment.
Afsharzadeh M; Hashemi M; Mokhtarzadeh A; Abnous K; Ramezani M
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1095-1110. PubMed ID: 28954547
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
13. Natural biodegradable polymers based nano-formulations for drug delivery: A review.
George A; Shah PA; Shrivastav PS
Int J Pharm; 2019 Apr; 561():244-264. PubMed ID: 30851391
[TBL] [Abstract][Full Text] [Related]
14. Polymeric protective agents for nanoparticles in drug delivery and targeting.
Mogoşanu GD; Grumezescu AM; Bejenaru C; Bejenaru LE
Int J Pharm; 2016 Aug; 510(2):419-29. PubMed ID: 26972379
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic Consequences of PLGA Nanoparticles in Docetaxel Drug Delivery.
Rafiei P; Haddadi A
Pharm Nanotechnol; 2017; 5(1):3-23. PubMed ID: 28948907
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
Narang AS; Chang RK; Hussain MA
J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
[TBL] [Abstract][Full Text] [Related]
17. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.
Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M
Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622
[TBL] [Abstract][Full Text] [Related]
18. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
19. Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate.
Lai P; Daear W; Löbenberg R; Prenner EJ
Colloids Surf B Biointerfaces; 2014 Jun; 118():154-63. PubMed ID: 24769392
[TBL] [Abstract][Full Text] [Related]
20. Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery.
Mohammed L; Ragab D; Gomaa H
Curr Pharm Des; 2016; 22(22):3332-52. PubMed ID: 26853596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
